Exploring the Connection Between Measles Vaccination and Childrens Cognitive Development

Researchers Investigate the Impact of Measles Vaccine on Child Growth, Cognition, and Schooling Outcomes

Understanding Measles

Measles is a highly contagious virus transmitted through respiratory droplets when an infected person coughs or sneezes. Symptoms typically appear about seven days after exposure and include fever, lethargy, coughing, congestion, and conjunctivitis (pink eye). Following these initial symptoms, a characteristic rash emerges, starting with small spots behind the ears and on the face, then spreading to the torso and limbs.

Deadly Complications of Measles

Despite its initial presentation, measles can lead to severe complications. The virus targets immune cells, allowing it to infect various organs and potentially resulting in numerous health issues. Complications include otitis media (middle ear inflammation leading to deafness), corneal scarring (which can cause blindness), croup, diarrhea, and pneumonia. Furthermore, measles can weaken the immune system, increasing susceptibility to secondary infections, such as bacterial pneumonia, which can be life-threatening. Encephalitis, or brain swelling, is another serious risk, particularly for infants and toddlers under five years old. Currently, there is no antiviral treatment for measles, highlighting the importance of preventive measures.

The Role of Measles Vaccinations

The measles vaccine, a live attenuated virus, was developed by cultivating the virus in chicken cells, resulting in a weakened strain that does not cause the severe illness associated with regular measles infections. This vaccine prepares the immune system to recognize and respond rapidly to the virus, providing lifelong protection against infection. Administered to children at nine months, with a booster shot given between fifteen and eighteen months, the measles vaccination has significantly reduced mortality rates, preventing approximately 21.1 million deaths between 2000 and 2017. The U.S. successfully eliminated measles in 2002, demonstrating the effectiveness of vaccination strategies. However, recent measles outbreaks in the U.S. and Europe have been attributed to vaccine hesitancy and increased global travel.

Addressing Vaccination Hesitancy

Concerns about vaccine safety have led some parents to delay or avoid vaccinating their children. Common side effects of the measles vaccine include fever, rash, and pain at the injection site. Rarely, febrile seizures and transient thrombocytopenia (low platelet count) can occur, but these conditions have no long-term health implications. While much attention is focused on potential adverse effects, recent research has begun to explore the possible benefits of the measles vaccine.

Potential Cognitive Benefits of the Measles Vaccine

A recent study published in Vaccine aimed to determine the impact of the measles vaccine on children’s cognitive development and educational outcomes. Researchers examined children in Ethiopia, India, and Vietnam, utilizing data from the Young Lives study, which included 2,000 children per country. Participants were divided into vaccinated and unvaccinated groups, and their cognitive abilities, schooling indicators, and growth were compared at ages 7-8 and again at 11-12. Growth was assessed using height, weight, and BMI, while cognitive function was measured through standardized tests, including the Peabody Picture Vocabulary Test (PPVT), mathematics assessments, and early-grade reading evaluations. The study found an association between vaccination and improved cognitive function, educational attainment, and growth.

Limitations of the Study

It is essential to recognize that this observational study has inherent biases. Confounding factors, such as nutrition, educational resources, children’s health status, and environmental influences, were not fully accounted for. Hence, while the study suggests a correlation between vaccination and positive outcomes, it does not establish a causal relationship. Additionally, one author disclosed a conflict of interest due to financial contributions from pharmaceutical companies manufacturing measles vaccines.

Conclusion

Despite these limitations, the possibility that the measles vaccine may offer additional benefits beyond preventing a serious disease is a hopeful prospect for public health.

References

Laksono, B. M., de Vries, R. D., McQuaid, S., Duprex, W. P. & de Swart, R. L. Measles Virus Host Invasion and Pathogenesis. Viruses 8, doi:10.3390/v8080210 (2016).
Goodson, J. L. & Seward, J. F. Measles 50 Years After Use of Measles Vaccine. Infect Dis Clin North Am 29, 725-743, doi:10.1016/j.idc.2015.08.001 (2015).
Holzmann, H., Hengel, H., Tenbusch, M. & Doerr, H. Eradication of measles: remaining challenges. Medical microbiology and immunology 205, 201-208 (2016).
Bankamp, B., Hickman, C., Icenogle, J. P. & Rota, P. A. Successes and challenges for preventing measles, mumps and rubella by vaccination. Current opinion in virology 34, 110-116 (2019).
Minor, P. D. Live attenuated vaccines: Historical successes and current challenges. Virology 479, 379-392 (2015).
Massad, E. Measles and human movement in Europe. Journal of travel medicine 25, tay091 (2018).
Dubé, E. et al. Improving Vaccination Rates: Vaccine acceptance, hesitancy and refusal in Canada: Challenges and potential approaches. Canada Communicable Disease Report 42, 246 (2016).
WHO, W. h. o. INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS MEASLES, MUMPS AND RUBELLA VACCINES. (2014).
Nandi, A. et al. Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam. Vaccine, doi:https://doi.org/10.1016/j.vaccine.2019.06.025 (2019).